Equity Capital Markets

Compass Therapeutics

08/25
|
$120.0 Million
c
Piper Sandler served as active bookrunner for Compass Therapeutics on its CMFO
Sub-Type
CMFO
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$130.0 Million
h
Savara
Confidentially Marketed Follow-On Offering
Active Bookrunner
u
Tamboran Resources
Confidentially Marketed Follow-On Offering
Co-Manager
$10.0 Million
d
Decatur Bancshares
Subordinated Notes
Sole Placement Agent
$603.8 Million
r
Praxis Precision Medicines
Confidentially Marketed Follow-On Offering
Active Bookrunner
$50.0 Million
s
Adagio Medical Inc.
PIPE
Sole Placement Agent
$100.0 Million
Inventiva
Inventiva
ATM Program Common Stock
Sole Sales Agent
$75.0 Million
r
Esperion Therapeutics
Confidentially Marketed Follow-On Offering
Lead Bookrunner
$368.4 Million
y
Neptune Flood Insurance
Initial Public Offering
Joint Bookrunner
$1.0 Billion
n
Netskope
Initial Public Offering
Passive Bookrunner
$729.1 Million
s
WaterBridge Resources
Initial Public Offering
Passive Bookrunner
$190.0 Million
w
Rithm Capital
Preferred Stock
Joint Bookrunner
$327.7 Million
r
LB Pharma
Initial Public Offering
Active Bookrunner
$906.6 Million
l
Figure Technology Solutions
Initial Public Offering
Co-Manager
$100.0 Million
r
CAMP4
PIPE
Sole Placement Agent
$2.1 Billion
American BTC
American Bitcoin
ATM Program Common Stock
Co-Manager
$100.0 Million
bm
Bright Minds Biosciences
ATM Program Common Stock
Lead Sales Agent

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.